Abstract
Chronic daily headache (CDH) is a frequently used but nonspecific term that includes all the headaches which are experienced on more than 15 days per month for at least 3 months. There are numerous headache disorders, both primary and secondary, that behave like this. They represent a great challenge to medical professionals and a burden to the patient and society. The primary CDHs (for which no underlying cause is found) are the most common. Of those, chronic migraine is the leading problem encountered in specialized headache clinics, much more common than other primary CDHs of long duration (≥4 h/day). Most important primary CDHs of short duration (<4 h/day) are the trigeminal autonomic cephalalgias (TACs), i.e., chronic cluster headache. There is a host of secondary causes of CDH, and they need to be carefully diagnosed based on history, examination, and additional investigations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Silberstein SD, Lipton RD, Saper JR. Chronic daily headache. In: Silberstein SD, Lipton RD, Dodick DW, editors. Wolff’s headache. 8th ed. New York: Raven Press; 2008. p. 315–77.
Tepper S, Tepper D. Diagnosis of primary chronic daily headaches. In: Tepper S, Tepper DE, editors. The Cleveland clinic manual of headache therapy. 2nd ed. Heidelberg New York Dordrecht London: Springer; 2014. p. 49.
Gladstone J, Eross E, Dodick D. Chronic daily headache: a rational approach to a challenging problem. Semin Neurol. 2003;23(3):265–75.
Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;36(3):630–808.
Cowan PR, Rapoport A, Blythe J. Comprehensive clinical report [Internet]. Available from http://www.bontriage.com
Olesen J, Rasmussen BK. The international headache society classification of chronic daily and near-daily headaches: a critique of the criticism. Cephalalgia. 1996;16(6):407–11.
Lipton RB, Serrano D, Buse DC, Pavlovic JM, et al. Improving the detection of chronic migraine: development and validation of identify chronic migraine (ID-CM). Cephalalgia. 2016;36(3):203–15.
Dodick DW, Loder EW, Manack Adams A, Buse DC, Fanning KM, Reed ML, Lipton RB. Assessing barriers to chronic migraine consultation, diagnosis and treatment: results from the chronic migraine epidemiology and outcomes (CAMEO) study. Headache. 2016;56(5):821–34.
Dodick DW, Silberstein SD. Chronic migraine. In: Dodick DW, Silberstein SD, editors. Migraine. 3rd ed. New York: Oxford University Press; 2016. p. 193–242.
Jensen R, Olesen J. Other refractory headaches: chronic tension-type headache, new daily persistent headache, cluster headache and other trigeminal autonomic cephalalgias, and posttraumatic headache. In: Schulman EA, Levin M, Lake III AE, Loder E, editors. Refractory migraine mechanism and management. New York: Oxford University Press; 2010. p. 373–96.
Purdy A. Differential diagnosis and investigation of refractory headache. In: Schulman EA, Levin M, Lake III AE, Loder E, editors. Refractory migraine mechanism and management. New York: Oxford University Press; 2010. p. 69–79.
John S, Singha AB, Calabrese L, Uchino K, Hammad T, Tepper S, Stillman M, Mills B, Thankachan T, Hajj-Ali RA. Long-term outcomes after reversible cerebral vasoconstriction syndrome. Cephalalgia. 2016;36(4):387–94.
Mokri B. Low cerebrospinal headache syndromes. Neurol Clin. 2004;22(1):55–74.
Forsyth PA, Posner JB. Headaches in patients with brain tumors: a study of 111 patients. Neurology. 1993;43(9):1678–83.
Lipton RB, Saper JR, Silberstein SD. Turning treatment failure into treatment success. In: Silberstein SD, Lipton RD, Dodick DW, editors. Wolff’s headache. 8th ed. New York: Raven Press; 2008. p. 793–803.
Baldwin K, Whiting C. Chronic meningitis: simplifying a diagnostic challenge. Curr Neurol Neurosci Rep. 2016;16(3):30. https://doi.org/10.1007/s11910-016-0630-0.
Lima Carvalho MF, de Medeiros JS, Valenca MM. Headache in recent onset hypothyroidism: prevalence, characteristics and outcome after treatment with levothyroxine. Cephalgia. 2016;37(10):938–46. pii: 0333102416658714. [Epub ahead of print]
Moreau T, Manceau E, Giroud-Baleydier F, Giroud M. Headache in hypothyroidism. Prevalence and outcome under thyroid hormone therapy. Cephalalgia. 1998;18(10):687–9.
Badhey A, Jategaonkar A, Angliin Kovacs AJ, Kadakia S, De Deyn PP, Ducic Y, Schantz S, Shin E. Eagle syndrome: a comprehensive review. Clin Neurol Neurosurg. 2017;159:34–8.
Di Paolo C, D’Urso A, Papi P, Di Sabato F, Rosella D, Pompa G, Polimeni A. Temporomandibular disorders and headache: a retrospective analysis of 1198 patients. Pain Res Manag. 2017;2017:3203027. https://doi.org/10.1155/2017/3203027. Epub 2017 Mar 21
Fromm GH. Facial pain with herpes zoster and postherpetic neuralgia and a comparison with trigeminal neuralgia. In: Herpes zoster and Postherpetic neuralgia. 2nd ed. Amsterdam: Elsevier; 2001. p. 151–9.
Jääskeläinen SK, Woda A. Burning mouth syndrome. Cephalalgia. 2017;37(7):627–47.
Nagel MA, Gilden D. Burning mouth syndrome associated with varicella zoster virus. BMJ Case Rep. 2016;2016:bcr2016215953. https://doi.org/10.1136/bcr-2016-215953.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Birlea, M., Green, M.W. (2019). Collecting the History in the CDH Patients. In: Green, M., Cowan, R., Freitag, F. (eds) Chronic Headache. Springer, Cham. https://doi.org/10.1007/978-3-319-91491-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-91491-6_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-91490-9
Online ISBN: 978-3-319-91491-6
eBook Packages: MedicineMedicine (R0)